JDRF to Honor Scientists for Their Outstanding Work in Advancing Type 1...
January 14th. Collectively, the three awards recognize individual scientists, teams or organizations for their T1D research innovation, achievement or clinical and translational work. read more
View ArticleAbout Type 1 Diabetes (T1D)
Join JDRF and connect with the T1D community for networking, information and support. Find fundraising and awareness events through your local chapter, branch or international affiliate. read more
View ArticleJDRF Supports Janssen’s Disease Interception Approach to Prevent the Clinical...
New York, NY, February, 12 2015 — JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research, announced today its alignment with an innovative scientific approach of...
View ArticleThe Serious Side of the Flu for People with T1D
DKA is normally seen in states of prolonged fasting or starvation. The body shifts metabolism from primarily using glucose to using an alternate fuel pathway, ketones, derived from fatty acids. A key...
View ArticleJDRF Announces New Partnership with the European Foundation for the Study of...
New York, NY, March 5, 2015 — JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research announced today a new research partnership with the European Foundation for the...
View ArticleYour design can supercharge T1D research
Kids, start your sketching! Children living with type 1 diabetes (T1D), ages 5 to 18, are encouraged to let their imaginations race for the checkered flag in the 2015 Race Car Design Contest for JDRF,...
View ArticleTwo-year $300 Million Extension of the Special Diabetes Program Allows for...
Washington, D.C., April 15, 2015 – The U.S. Senate overwhelmingly approved legislation last night for a two-year extension of the Special Diabetes Program (SDP)—an initiative that accounts for roughly...
View ArticleA New Study Points to a Possible Oral Vaccine to Decrease Childhood Type 1...
New York, NY, April 21, 2015 – Children with type 1 diabetes (T1D) must inject insulin several times a day for the rest of their lives because their own immune systems have destroyed the pancreatic...
View ArticleJDRF Announces $1.8 Million Two-year Partnership with Lilly to Provide...
New York, NY May 6, 2015 — JDRF, the leading global organization funding type 1 diabetes (T1D) research, and Eli Lilly and Company, a global leader in diabetes care announced a two-year partnership...
View ArticleJDRF-Supported Researchers Make Gains in Designing Islet Cell Encapsulation...
New York, NY, May 18, 2015 –Type 1 diabetes (T1D) researchers have known for nearly two decades that it is possible to make people living with T1D insulin independent through the use of islet...
View ArticleJDRF Response to CrossFit
At JDRF, we don’t believe diabetes is a laughing matter or something to be joked about. During the week of June 29, posted insensitive images and misleading information regarding diabetes, both type 1...
View ArticleSernova Corp. Announces Collaboration with Massachusetts General Hospital to...
LONDON, ONTARIO ( – July 7, 2015) – Sernova Corp. read more
View ArticleDay one of 2015 JDRF Children’s Congress is a wrap!
This is Brian Herrick and Kady Helme reporting each day from 2015 JDRF Children’s Congress. read more
View ArticleWhite House Honors Tidepool for Its Development of T1D ...
White House Honors Tidepool for Its Development of T1D ... read more
View ArticleViaCyte Announces Highly Anticipated Encapsulation Clinical Trial Site...
TORONTO, July 29, 2015 — ViaCyte, Inc. announced the opening of a second site in its Phase 1/2 trial called STEP ONE, or Safety, Tolerability and Efficacy of VC-01™ Combination Product in Type One...
View ArticleDiscovering the Best Size and Shape for Beta Cell Replacement
In a recent Nature Materials’ publication, Daniel Anderson, Ph.D., of the Massachusetts Institute of Technology (MIT) detailed how the immune system responds to implanted material depending on its size...
View ArticleJDRF Mourns the Passing of Senator Dick Schweiker
JDRF is deeply saddened by the passing of type 1 diabetes (T1D) champion and trusted strategic advisor, Senator Dick Schweiker. He led the fight against diabetes and authored bills creating the...
View ArticleMoving Toward Early Diagnosis
Researchers have known for some time that the risk of developing type 1 diabetes (T1D) can be detected by looking for the presence of specific autoantibodies. That knowledge has allowed JDRF to support...
View ArticleStrengthen the Defensive Line
JDRF-funded researchers are using gene therapy in a promising approach to stopping the autoimmune attack that triggers type 1 diabetes (T1D). The gene therapy manipulates the body’s varied immune...
View ArticleUnderstanding T1D through Organ Donation
In 2007, JDRF awarded a grant for more than $7 million to Mark Atkinson, Ph.D., at the University of Florida to a unique, first of its kind biorepository for tissues of type 1 diabetes (T1D) including...
View Article